NDC 55513-190

Neulasta

Pegfilgrastim

Neulasta is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Pegfilgrastim.

• Product ID: 55513-190_1ca38d81-c6b9-4a90-97d3-35089b4aba67
• NDC: 55513-190
• Product Type: Human Prescription Drug
• Proprietary Name: Neulasta
• Generic Name: Pegfilgrastim
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2002-04-01
• Marketing Category: BLA / BLA
• Application Number: BLA125031
• Labeler Name: Amgen Inc
• Substance Name: PEGFILGRASTIM
• Active Ingredient Strength: 6 mg/.6mL
• Pharm Classes: Granulocyte Colony-Stimulating Factor [CS],Granulocyte-Macrophage Colony-Stimulating Factor [CS],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 55513-190-01

1 SYRINGE in 1 CARTON (55513-190-01) > .6 mL in 1 SYRINGE

• Marketing Start Date: 2002-04-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55513-190-01 [55513019001]

Neulasta INJECTION

• Marketing Category: BLA
• Application Number: BLA125031
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2002-04-01

Drug Details

Pharmacological Class

• Granulocyte Colony-Stimulating Factor [CS]
• Granulocyte-Macrophage Colony-Stimulating Factor [CS]
• Increased Myeloid Cell Production [PE]
• Leukocyte Growth Factor [EPC]

Medicade Reported Pricing

55513019001 NEULASTA 6 MG/0.6 ML SYRINGE

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Neulasta" or generic name "Pegfilgrastim"

NDC	Brand Name	Generic Name
55513-190	Neulasta	pegfilgrastim
55513-192	Neulasta	pegfilgrastim
67457-833	Fulphila	pegfilgrastim
70121-1627	FYLNETRA	pegfilgrastim